YUHAN CORPORATION Logo

YUHAN CORPORATION

Develops and manufactures pharmaceuticals, APIs, veterinary drugs, and offers CDMO services.

000100 | KO

Overview

Corporate Details

ISIN(s):
KR7000100008
LEI:
Country:
South Korea
Address:
서울특별시 동작구 노량진로 74, 서울특별시

Description

Yuhan Corporation, established in 1926, is an integrated healthcare company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products. Its diverse portfolio encompasses prescription drugs, over-the-counter (OTC) medications, Active Pharmaceutical Ingredients (APIs), and intermediates for various therapeutic areas, including antibiotics and antivirals. The company also produces veterinary drugs and household goods. In addition to its own product lines, Yuhan operates as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive services to the pharmaceutical sector. Through its affiliates, the company is also involved in specialized areas such as nutrient infusion solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
기업설명회(IR)개최(안내공시)
Korean 6.2 KB
2025-09-02 00:00
자기주식취득결과보고서
Korean 35.6 KB
2025-08-27 00:00
단일판매ㆍ공급계약체결
Korean 7.7 KB
2025-08-27 00:00
주식등의대량보유상황보고서(약식)
Korean 72.8 KB
2025-08-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-20 00:00
단일판매ㆍ공급계약체결
Korean 7.7 KB
2025-08-18 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 19.7 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 5.3 MB
2025-08-01 00:00
신탁계약해지결과보고서
Korean 20.8 KB
2025-07-30 00:00
영업(잠정)실적(공정공시)
Korean 14.5 KB
2025-07-30 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 28.6 KB
2025-07-29 00:00
기업설명회(IR)개최(안내공시)
Korean 6.0 KB
2025-07-01 00:00
주요사항보고서(자기주식취득결정)
Korean 34.0 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-06-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all YUHAN CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for YUHAN CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for YUHAN CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.